Skip to main content
. 2014 Apr;26(2):192–199. doi: 10.3978/j.issn.1000-9604.2014.04.06

Table 1. The correlations between lymph node metastasis and clinicopathological features of EGC patients.

Clinicopathological features Lymph node metastasis
P
Negative (n=209) Positive (n=17)
Gender 0.885
   Male 144 (92.3%) 12 (7.7%)
   Female 65 (92.9%) 5 (7.1%)
Age (year) 0.860
   <60 106 (92.2%) 9 (7.8%)
   360 103 (92.8%) 8 (7.2%)
Tumor location 0.955
   Upper 1/3 29 (93.5%) 2 (6.5%)
   Middle 1/3 56 (91.8%) 5 (8.2%)
   Lower 1/3 124 (92.5%) 10 (7.5%)
Macroscopic type 0.106
   I/II 139 (94.6%) 8 (5.4%)
   III/Mixed 70 (88.6%) 9 (11.4%)
Size (cm) 0.319
   <2.0 100 (94.3%) 6 (5.7%)
   32.0 109 (90.8%) 11 (9.2%)
Histology 0.783
   Adenocarcinoma 147 (91.9%) 13 (8.1%)
   Other types* 62 (93.9%) 4 (6.1%)
Differentiation 0.022
   Differentiated 97 (97.0%) 3 (3.0%)
   Undifferentiated 112 (88.9%) 14 (11.1%)
Ulcer 0.721
   Absent 179 (92.7%) 14 (7.3%)
   Present 30 (90.9%) 3 (9.1%)
Lymphovascular invasion 0.000
   Absent 194 (95.1%) 10 (4.9%)
   Present 15 (68.2%) 7 (31.8%)
Depth of invasion 0.001
   Mucosa 124 (97.6%) 3 (2.4%)
   Submucosa 85 (85.9%) 14 (14.1%)

EGC, early gastric cancer; *, signet-ring cell carcinoma, mucinous adenocarcinoma and et al.